Evolus

Evolus Reports Q1 2026 Results; Posts Second Straight Positive Adjusted EBITDA and Reaffirms Outlook

Revenue grows 7% year over year to $73.1 million as the company advances toward full-year profitability and sustained double-digit growth Evolus, reported strong financial and operational performance for the first quarter of 2026, marking a notable continuation of its profitability…

Read MoreEvolus Reports Q1 2026 Results; Posts Second Straight Positive Adjusted EBITDA and Reaffirms Outlook
Anthem

Anthem Blue Cross and Blue Shield Helps Georgia Small Businesses Cut Costs and Improve Health

Anthem Blue Cross and Blue Shield Supports Georgia Small Businesses in Reducing Costs and Enhancing Health Outcomes As healthcare costs continue to climb across the United States, small businesses in Georgia are facing increasing pressure to provide quality employee benefits…

Read MoreAnthem Blue Cross and Blue Shield Helps Georgia Small Businesses Cut Costs and Improve Health
Leon

Leon Medical Centers Shows Strong Results from PERS & Fall Detection Program with MedSys Health

Leon Medical Centers Demonstrates Strong Clinical and Operational Impact Through Advanced Fall Detection and PERS Program in Collaboration with MedSys Health Leon Medical Centers, a prominent healthcare services organization dedicated to serving Medicare patients across South Florida, has reported highly…

Read MoreLeon Medical Centers Shows Strong Results from PERS & Fall Detection Program with MedSys Health
Trividia

Trividia Health Issues Correction Notice for TRUE METRIX Blood Glucose Monitoring Systems

Updated Labeling Guidance and Safety Measures Address E-5 Error Code While Company Develops Long-Term Software Solution Trividia Health, Inc., a globally recognized leader in diabetes care and blood glucose monitoring solutions, has issued an updated communication regarding its previously announced…

Read MoreTrividia Health Issues Correction Notice for TRUE METRIX Blood Glucose Monitoring Systems
Jakafi

Jakafi XR Wins FDA Approval for Myelofibrosis, Polycythemia Vera, and GVHD Treatment

Incyte Secures FDA Approval for Jakafi XR™ (Ruxolitinib Extended-Release), Expanding Treatment Options for Patients with Blood Disorders and GVHD Incyte has announced that the U.S. Food and Drug Administration has granted approval to Jakafi XR™ (ruxolitinib), a once-daily extended-release oral…

Read MoreJakafi XR Wins FDA Approval for Myelofibrosis, Polycythemia Vera, and GVHD Treatment
FDA

FDA Panel Backs TRUQAP for PTEN-Deficient Metastatic Hormone-Sensitive Prostate Cancer

ODAC Endorses TRUQAP Combination Therapy Based on Phase III CAPItello-281 Results Showing Improved Progression-Free Survival and Addressing Unmet Need The U.S. Food and Drug Administration’s Oncologic Drugs Advisory Committee (ODAC) has voted in favor of a new treatment approach involving…

Read MoreFDA Panel Backs TRUQAP for PTEN-Deficient Metastatic Hormone-Sensitive Prostate Cancer
Canadian

Canadian Association of Optometrists Launches “GetEyeWise” Campaign for Vision Health Month

Canadian Association of Optometrists Launches “GetEyeWise” Campaign to Promote Vision Health Awareness If reading fine print has become a challenge, it may be time to “GetEyeWise.” That’s the message behind a nationwide public education campaign launched by the Canadian Association…

Read MoreCanadian Association of Optometrists Launches “GetEyeWise” Campaign for Vision Health Month
Cairn

Cairn Surgical Announces Positive Pivotal Trial Results for Breast Cancer Locator System

Cairn Surgical, Inc. Announces Pivotal Trial Success for Breast Cancer Locator System, Demonstrating Improved Surgical Outcomes Cairn Surgical, Inc., a medical technology innovator focused on improving precision in breast cancer surgery, has announced encouraging results from its pivotal clinical trial…

Read MoreCairn Surgical Announces Positive Pivotal Trial Results for Breast Cancer Locator System